Published online May 1, 2006
PEDIATRICS Vol. 117 No. 5 May 2006, pp. 1626-1631 (doi:10.1542/peds.2005-1767)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, S. P.
Right arrow Articles by Barkovich, A. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Miller, S. P.
Right arrow Articles by Barkovich, A. J.
Related Collections
Right arrow Premature & Newborn

Prolonged Indomethacin Exposure Is Associated With Decreased White Matter Injury Detected With Magnetic Resonance Imaging in Premature Newborns at 24 to 28 Weeks' Gestation at Birth

Steven P. Miller, MDa,b, Eleanor E. Mayer, BAc, Ronald I. Clyman, MDd, David V. Glidden, PhDe, Shannon E.G. Hamrick, MDd and A. James Barkovich, MDb

a Departments of Neurology
c Radiology
d Pediatrics
e Epidemiology and Biostatistics, University of California, San Francisco, California
b Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada

OBJECTIVES. Newborns delivered before 28 weeks' gestation commonly have white matter lesions on MRI that are associated with adverse neurodevelopmental outcomes. Our objective was to determine the risk factors for MRI-detectable white matter injury in infants delivered before 28 weeks' gestation who were treated with prophylactic indomethacin.

METHODS. This was a prospective cohort study conducted at the intensive care nursery at University of California San Francisco Children's Hospital. Patients included 57 premature newborns between 24 and 27 (+6 days) weeks' gestation at birth (October 1998 to October 2004). We identified perinatal and neonatal risk factors associated with moderate-severe "white matter injuries" (T1 signal abnormalities >2 mm or >3 areas of T1 abnormality) and moderate-severe "brain abnormality" (moderate-severe white matter injuries, any degree of ventriculomegaly, or severe intraventricular hemorrhage) on MRI. Infants were studied with MRI at 31.1 weeks’ postmenstrual age (median).

RESULTS. Moderate-severe white matter injuries were detected in 12 (21%) of 53 preterm newborns, and 20 (35%) of 57 had moderate-severe brain abnormality. Prolonged indomethacin exposure was the only risk factor independently associated with a lower risk of white matter injury or brain abnormality, even when adjusting for the presence of a hemodynamically significant PDA, gestational age at birth, prenatal betamethasone, systemic infection, and days of mechanical ventilation.

CONCLUSIONS. In this observational study, a longer duration of indomethacin exposure was associated with less white matter injury in infants delivered before 28 weeks' gestation. A randomized trial of prolonged indomethacin treatment is needed to determine whether indomethacin can decrease white matter injury and neurodevelopmental abnormalities.

Key Words: periventricular leukomalacia • MRI • brain injury • patent ductus arteriosus • indomethacin

Abbreviations: IVH—intraventricular hemorrhage • PMA—postmenstrual age • PDA— patent ductus arteriosus • CI—confidence interval • OR—odds ratio

Accepted Oct 17, 2005.




This article has been cited by other articles:


Home page
 NeoReviewsHome page
S. A. Back and S. P. Miller
Cerebral White Matter Injury: The Changing Spectrum in Survivors of Preterm Birth
NeoReviews, October 1, 2007; 8(10): e418 - e424.
[Abstract] [Full Text] [PDF]